Results 261 to 270 of about 235,338 (351)
111. A New Method for the Direct Measurement of the Intracranial Pressure
Kinjiro Iwata +4 more
openalex +2 more sources
Abstract Background Anxiety and autonomic dysfunction are frequent non‐motor symptoms of Parkinson's disease (PD). Their relationship, as well as the neural mechanisms underlying this relationship, remain unexplored. Objectives We aimed to investigate the relationship between cardiovascular functions and anxiety in PD and the structural neural changes ...
Lucia Ricciardi +9 more
wiley +1 more source
Raised intracranial pressure alters cortical vascular function and cephalic allodynia. [PDF]
Grech O +7 more
europepmc +1 more source
ABSTRACT Purpose To develop accelerated 3D phase contrast (PC) MRI using jointly learned wave encoding and reconstruction. Methods Pseudo‐fully sampled neurovascular 4D flow data (N = 40) and a simulation framework were used to learn phase encoding locations, wave readout parameters, and model‐based reconstruction network (MoDL) for a rapid 3D PC scan (
Chenwei Tang +7 more
wiley +1 more source
Raised Intracranial Pressure in Seizures Induced by Electroconvulsive Therapy. [PDF]
Spoor JKH +12 more
europepmc +1 more source
Postoperative intracranial pressure monitoring in patients with cerebral aneurysms.
Yoji Node, Kozo YAJIMA, Shozo Nakazawa
openalex +2 more sources
Relaxivity of Gadobutrol and Gadoteric Acid in Cerebrospinal Fluid at 3T
ABSTRACT Purpose The aim was to estimate T1 relaxivity of gadobutrol and gadoteric acid in cerebrospinal fluid (CSF) at 3T, to support research on CSF‐flow and the glymphatic system in humans utilizing T1 mapping after intrathecal injection. Methods Using a phantom, relaxivity was estimated for gadobutrol and gadoteric acid in lumbar CSF and an ...
Sofia Behndig +5 more
wiley +1 more source
Intracranial Pressure-Guided Therapy in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Cerebral Edema: A Case Report. [PDF]
Khalifa H, Abdulmajeed M.
europepmc +1 more source
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden +6 more
wiley +1 more source
Intracranial pressure and pulsatility in different head and body positions. [PDF]
Bancroft MJ +7 more
europepmc +1 more source

